Fenwick & West has advised Vast. Vast, a company focused on the development of next-generation space stations, has announced the completion of a $500 million funding...
Vast Secures $500 Million Funding to Advance Space Station Initiatives
Servier to Acquire Day One Biopharmaceuticals in $2.5 Billion Transaction
Baker McKenzie has advised Servier, and Fenwick & West has advised Day One Biopharmaceuticals. Wilson Sonsini Goodrich & Rosati advised Day One on IP matters related...
BioAge Labs Completes $115 Million Upsized Public Offering
Fenwick & West has advised BioAge Labs, Inc. Cooley LLP has represented the underwriters. BioAge Labs, Inc., a clinical-stage biopharmaceutical company (Nasdaq: BIOA), has completed an...
Day One Biopharmaceuticals to Acquire Mersana Therapeutics in Transaction Valued Up to $285 Million
Wilmer Cutler Pickering Hale and Dorr has advised Mersana Therapeutics. Fenwick & West has advised Day One Biopharmaceuticals. Wilson Sonsini Goodrich & Rosati advised Day One...
Figma Announces $1.2 Billion Initial Public Offering
Fenwick has advised Figma on the offering, Latham & Watkins has advised the underwriters. Whalen LLP has acted as counsel for the selling stockholders. Figma, a...
Scopely’s Acquisition of Niantic Games Business
Fenwick & West is serving as legal counsel to Niantic and Skadden is serving as legal counsel to Scopely on the deal. Scopely, the #1 mobile...
Maze Therapeutics’ $140 Million Upsized Initial Public Offering
Fenwick & West represented Maze Therapeutics in the offering, and Davis Polk & Wardwell represented the underwriters. Maze Therapeutics, Inc. (Nasdaq: MAZE) announced its upsized initial...
FalconX’s Acquisition of Arbelos Markets
Fenwick & West represented Arbelos Markets in the transaction. FalconX, a leading digital asset prime broker, announced its acquisition of Arbelos Markets, a trading firm specializing...
BioAge Labs’ $238 Million Upsized Initial Public Offering
Fenwick & West represented BioAge Labs, Inc. in the offering, and Cooley represented the underwriters. BioAge Labs, Inc. (Nasdaq: BIOA), a clinical-stage biopharmaceutical company developing therapeutic...